ATE224376T1 - Piperazinderivate zur replikationshemmung von menschlichem immundefizienz virus - Google Patents

Piperazinderivate zur replikationshemmung von menschlichem immundefizienz virus

Info

Publication number
ATE224376T1
ATE224376T1 AT99929400T AT99929400T ATE224376T1 AT E224376 T1 ATE224376 T1 AT E224376T1 AT 99929400 T AT99929400 T AT 99929400T AT 99929400 T AT99929400 T AT 99929400T AT E224376 T1 ATE224376 T1 AT E224376T1
Authority
AT
Austria
Prior art keywords
immunodeficiency virus
human immunodeficiency
piperazine derivatives
replication inhibition
cr9r10r11
Prior art date
Application number
AT99929400T
Other languages
English (en)
Inventor
Francoise Heymans
Nathalie Dereuddre-Bosquet
Jean-Jacques Godfroid
Aazdine Lamouri
Pascal Clayette
Marc Martin
Original Assignee
Univ Paris 7 Denis Diderot
Commissariat Energie Atomique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Paris 7 Denis Diderot, Commissariat Energie Atomique filed Critical Univ Paris 7 Denis Diderot
Application granted granted Critical
Publication of ATE224376T1 publication Critical patent/ATE224376T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99929400T 1998-07-06 1999-07-05 Piperazinderivate zur replikationshemmung von menschlichem immundefizienz virus ATE224376T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9808600A FR2780649B1 (fr) 1998-07-06 1998-07-06 Derives de la piperazine pour l'inhibition de la replication du virus de l'immunodeficience humaine
PCT/FR1999/001615 WO2000001677A1 (fr) 1998-07-06 1999-07-05 Derives de la piperazine pour l'inhibition de la replication du virus de l'immunodeficience humaine

Publications (1)

Publication Number Publication Date
ATE224376T1 true ATE224376T1 (de) 2002-10-15

Family

ID=9528286

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99929400T ATE224376T1 (de) 1998-07-06 1999-07-05 Piperazinderivate zur replikationshemmung von menschlichem immundefizienz virus

Country Status (11)

Country Link
US (1) US6531476B1 (de)
EP (1) EP1095029B1 (de)
JP (1) JP2002519413A (de)
AT (1) ATE224376T1 (de)
AU (1) AU4622899A (de)
CA (1) CA2337059A1 (de)
DE (1) DE69903040T2 (de)
DK (1) DK1095029T3 (de)
ES (1) ES2184467T3 (de)
FR (1) FR2780649B1 (de)
WO (1) WO2000001677A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7354923B2 (en) * 2001-08-10 2008-04-08 Palatin Technologies, Inc. Piperazine melanocortin-specific compounds
US7655658B2 (en) * 2001-08-10 2010-02-02 Palatin Technologies, Inc. Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
US7456184B2 (en) * 2003-05-01 2008-11-25 Palatin Technologies Inc. Melanocortin receptor-specific compounds
US7732451B2 (en) * 2001-08-10 2010-06-08 Palatin Technologies, Inc. Naphthalene-containing melanocortin receptor-specific small molecule
WO2003013571A1 (en) * 2001-08-10 2003-02-20 Palatin Technologies, Inc. Peptidomimetics of biologically active metallopeptides
US7718802B2 (en) 2001-08-10 2010-05-18 Palatin Technologies, Inc. Substituted melanocortin receptor-specific piperazine compounds
US7727990B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Melanocortin receptor-specific piperazine and keto-piperazine compounds
US7727991B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Substituted melanocortin receptor-specific single acyl piperazine compounds
US7968548B2 (en) 2003-05-01 2011-06-28 Palatin Technologies, Inc. Melanocortin receptor-specific piperazine compounds with diamine groups
WO2005079799A1 (en) * 2004-02-13 2005-09-01 Glaxo Group Limited 4-acyl-piperazines as anti-viral agents
US7709484B1 (en) 2004-04-19 2010-05-04 Palatin Technologies, Inc. Substituted melanocortin receptor-specific piperazine compounds
US7834017B2 (en) 2006-08-11 2010-11-16 Palatin Technologies, Inc. Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents
WO2015013835A1 (en) * 2013-07-31 2015-02-05 Merck Sharp & Dohme Corp. Piperazine derivatives as hiv protease inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8823776D0 (en) * 1988-10-11 1988-11-16 Scras New 2-methoxycarbonyl sustituted n n'-di-(trimethoxybenzoyl)piperazines
GB8823775D0 (en) 1988-10-11 1988-11-16 Scras New 2-carbonyl substituted n n'-di-(trimethoxybenzoyl)piperazines
US4997836A (en) * 1988-11-11 1991-03-05 Takeda Chemical Industries, Ltd. Trisubstituted piperazine compounds, their production and use
GB8908587D0 (en) * 1989-04-15 1989-06-01 Scras Societe De Conseils De R New 2-substituted n,n'-ditrimethoxybenzoyl piperazines
HUT74681A (en) * 1993-12-15 1997-01-28 Merck & Co Inc N-(2-hydroxy-1-indenyl)-2-phenylmethyl-4-hydroxy-5-(2-carboxamido-piperazinyl)-pentaneamide derivatives of hiv protease inhibitor activity and phrmaceutical compositions contining them

Also Published As

Publication number Publication date
EP1095029B1 (de) 2002-09-18
WO2000001677A1 (fr) 2000-01-13
FR2780649A1 (fr) 2000-01-07
AU4622899A (en) 2000-01-24
US6531476B1 (en) 2003-03-11
CA2337059A1 (fr) 2000-01-13
ES2184467T3 (es) 2003-04-01
DE69903040D1 (de) 2002-10-24
EP1095029A1 (de) 2001-05-02
JP2002519413A (ja) 2002-07-02
DE69903040T2 (de) 2003-06-26
DK1095029T3 (da) 2003-01-27
FR2780649B1 (fr) 2001-03-09

Similar Documents

Publication Publication Date Title
ATE224376T1 (de) Piperazinderivate zur replikationshemmung von menschlichem immundefizienz virus
BR0309447A (pt) Composto, agente, processos para a preparação dos mesmos, e para o combate do crescimento de plantas indesejadas, e, uso do composto
HUP0201935A2 (hu) A SYK tirozin-protein-kináz inhibitoraiként alkalmazható purinszármazékok
NO954427L (no) Hiv-proteaseinhibitorer som er anvendbare for behandling av AIDS
CY1111909T1 (el) Παραγωγα [[2-(αμινο-3,4-διοξο-1-κυκλοβουτεν-1-υλ)amino] αλκυλ]-οξεος για τη θεραπεια του πονου
ATE103812T1 (de) Zusammensetzung zur behandlung von ischaemischen stoerungen in organen.
TW427887B (en) Pharmaceutical composition comprising a benzimidazole derivative for treating viral infections
FI952424A (fi) 11,21-bisfenyyli-19-norpregaanijohdannaisia
DZ1694A1 (fr) "n-(2-Aminoethyl)-benzothialozones".
NO975295L (no) 6-Karbamido-dihydropyran-derivater
DK0629635T3 (da) Hidtil ukendte 19-nor-11beta-phenoxysulfonamid- eller 11beta-phenoxysulfonylureasteroider, fremgangsmåde og mellemprodukter til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf
DK26289A (da) Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia
CY1106212T1 (el) Χρηση παραγωγων θειαζολης δια την παρασκευη ενος φαρμακου για την προστασια των μιτοχονδριων
ATE137759T1 (de) S'-adenosyl-methionin-decarboxylase-inhibitoren
DK0570245T3 (da) Octahydronaphthalenoximderivater til inbibering af kolesterolbiosyntese, deres fremstilling og anvendelse
DE3366181D1 (en) 2-aminomethyl-6-sulfamoylphenol derivatives, process for their preparation, their use and pharmaceutical preparations based on these compounds
ATE94050T1 (de) Mittel zur verhinderung von zahnbelagbildung.
DK0413278T3 (da) Anvendelse af xanthinderivater mod mavesår
ATE158503T1 (de) Aids-virus-infektion hemmende zusammensetzung
DK0871611T3 (da) Hidtil ukendte glycylanilidderivater, deres fremstilling og deres terapeutiske anvendelse
HUP0300996A2 (hu) 4,5-Dihidro-tiazol-2-ilamin származékok, eljárás előállításukra és alkalmazásuk NO szintáz inhibitorokként és ezeket tartalmazó gyógyszerkészítmények
NO930247L (no) 1,4-disubstituerte piperaziner
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1095029

Country of ref document: EP

REN Ceased due to non-payment of the annual fee